Aspirin tablets

DRUG2 trials

Sponsors

AstraZeneca, PLx Pharma

Conditions

Coronary Artery DiseaseGastroduodenal Ulceration

Phase 2

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

CompletedNCT00528411

AstraZenecaCoronary Artery Disease

Start: 2007-10-31End: 2009-03-31Updated: 2012-01-13

Evaluation of Upper GI Ulceration Induced by PL2200 Versus Aspirin in At-Risk Subjects

CompletedNCT01646814

PLx PharmaGastroduodenal Ulceration

Start: 2012-09-30End: 2013-06-30Updated: 2022-06-07

Related Papers

Incidence of dyspnea and assessment of cardiac and pulmonary function in patients with stable coronary artery disease receiving ticagrelor, clopidogrel, or placebo in the ONSET/OFFSET study.

2010-07-01132 citations